Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)

Volume: 46, Issue: 5
Published: Sep 8, 2021
Abstract
Despite the marked success of molecular targeted therapy in lung cancer in this era of personalized medicine, its efficacy has been limited by the presence of resistance mechanisms. The prognosis of patients with lung cancer remains poor, and there is an unmet need to develop more effective therapies to improve clinical outcomes. The increasing insight into the human immune system has led to breakthroughs in immunotherapy and has prompted...
Paper Details
Title
Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)
Published Date
Sep 8, 2021
Volume
46
Issue
5
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.